Asma en el embarazo
Resumen
En este articulo se revisan las modificaciones fisiológicas que se producen durante el embarazo, los efectos del embarazo sobre el asma y las consecuencias del asma sobre el desarrollo fetal. Además se muestra la evidencia actual respecto a la seguridad de los tratamientos farmacológicos del asma durante el embarazo y un reciente algoritmo de manejo multidisciplinar de la asmática embarazada. En el seguimiento de una paciente con asma gestante se recomienda emplear medidas objetivas para prescribir la medicación necesaria para mantener el control del asma y efectuar visitas periódicas con tareas educativas en cada una de ellas para mejorar la adherencia y enseñar a la paciente a reconocer los síntomas de pérdida de control.
Referencias
Murphy VE, Gibson PG. Asthma in Pregnancy. Clin Chest
Med. 2011;32:93–110.
Grindheim G, Toska K, Estensen ME, Rosseland LA.
Changes in pulmonary function during pregnancy: A
longitudinal cohort study. BJOG. 2012;119:94–101.
Wise RA, Polito AJ, Krishnan V. Respiratory physiologic
changes in pregnancy. Vol. 26. Immunol Allergy Clin
North Am. 2006;26:1–12.
Murphy VE, Gibson PG, Smith R. Asma during pregnancy:
mechanisms and treatment implications. Eur Respir J.
;25:731–50.
Kim S, Kim J, Park SY, Um HY, Kim K, Kim Y, et al. Effect
of pregnancy in asthma on health care use and perinatal
outcomes. J Allergy Clin Immunol. 2015;136:1215–
Disponible en: http://dx.doi.org/10.1016/j.
jaci.2015.04.043.
Gluck JC, Gluck P. The effects of pregnancy on asthma: a
prospective study. Ann Allergy. 1976;37:164–8. Disponible
en: http://www.ncbi.nlm.nih.gov/pubmed/962194.
Murphy VE. Managing asthma in pregnancy. Breathe
(Sheff). 2015;11:259–67.
Niswander KR, Berendes H, Deutschberger J, Lipko
N, Westphal MC. Fetal morbidity following potentially
anoxigenic obstetric conditions. V. Organic heart disease.
Am J Obstet Gynecol. 1967;98:871–6. Disponible en:
https://liverpool.idm.oclc.org/login?url=http://search.
ebscohost.com/login.aspx?direct=true&db=cmedm&AN
=6027717&site=ehost-live&scope=site.
Perlow JH, Montgomery D, Morgan MA, Towers CV,
Pronto M. Severity of asthma and perinatal outcome. Am J
Obstet Gynecol. 1992;167:963–7.
Schatz M, Zeiger RS, Hoffman CP. Intrauterine growth
is related to gestational pulmonary function in pregnant
asthmatic women. Chest. 1990;98:389–92.
Breton MC, Beauchesne MF, Lemière C, Rey É, Forget A,
Blais L. Risk of perinatal mortality associated with inhaled
corticosteroid use for the treatment of asthma during
pregnancy. J Allergy Clin Immunol. 2010;126:772–7.
Murphy VE, Wang G, Namazy J, Powell H, Gibson PG,
Chambers C, et al. The risk of congenital malformations,
perinatal mortality and neonatal hospitalisation among
pregnant women with asthma: a systematic review and
meta-analysis. BJOG. 2013;120:812–22. Disponible en:
http://www.ncbi.nlm.nih.gov/pubmed/23530780.
Tata LJ, Lewis SA, McKeever TM, Smith CJ, Doyle P,
Smeeth L, et al. A comprehensive analysis of adverse
obstetric and pediatric complications in women with
asthma. Am J Respir Crit Care Med. 2007;175:991–7.
Mendola P, Laughon SK, Männistö TI, Leishear K, Reddy
UM, Chen Z, et al. Obstetric complications among US
women with asthma. Am J Obstet Gynecol. 2013;208:e1–8.
Källén B, Rydhstroem H, Aberg A. Asthma during
pregnancy--a population based study. Eur J Epidemiol.
;16:167–71. Disponible en: http://www.ncbi.nlm.
nih.gov/pubmed/10845267.
Wang G, Murphy VE, Namazy J, Powell H, Schatz M,
Chambers C, et al. The risk of maternal and placental
complications in pregnant women with asthma: a systematic
review and meta-analysis. J Matern Fetal Neonatal Med.
;27:934–42.
Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett
WS, Leaderer BP. Asthma symptoms, severity, and drug
therapy: A prospective study of effects on 2205 pregnancies.
Obstet Gynecol. 2003;102:739–52.
Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar
L, Petitti D. The safety of asthma and allergy medications
during pregnancy. J Allergy Clin Immunol. 1997;100:301–6.
Norjavaara E, De Verdier MG. Normal pregnancy
outcomes in a population-based study including 2,968
pregnant women exposed to budesonide. J Allergy Clin
Immunol. 2003;111:736–42. Disponible en: http://www.
ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=P
ubMed&dopt=Citation&list_uids=12704351.
Martel MJ, Rey E, Beauchesne MF, Perreault S, Lefebvre
G, Forget A, et al. Use of inhaled corticosteroids during
pregnancy and risk of pregnancy induced hypertension:
nested case-control study. BMJ. 2005;330:230. Disponible
en: http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=546071&tool=pmcentrez&rendertype=abstract.
Källén B, Rydhstroem H, Aberg A. Congenital
malformations after the use of inhaled budesonide in early
pregnancy. Obs Gynecol. 1999;93:392–5.
Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée
P, Rey É, et al. Relative perinatal safety of salmeterol vs
formoterol and fluticasone vs budesonide use during
pregnancy. Ann Allergy Asthma Immunol. 2017;112:459–
Disponible en: http://dx.doi.org/10.1016/j.
anai.2014.02.010.
Garne E, Hansen AV, Morris J, Zaupper L, Addor MC,
Barisic I, et al. Use of asthma medication during pregnancy
and risk of specific congenital anomalies: a european
case-malformed control study. J Allergy Clin Immunol.
;136:1496–502.
Eltonsy S, Kettani FZ, Blais L. Beta2-agonists use during
pregnancy and perinatal outcomes: a systematic review.
Respir Med. 2014;108:9–33. Disponible en: http://www.
resmedjournal.com/article/S095461111300262X/fulltext.
Sarkar M, Koren G, Kalra S, Ying A, Smorlesi C, De Santis
M, et al. Montelukast use during pregnancy: A multicentre,
prospective, comparative study of infant outcomes. Eur J
Clin Pharmacol. 2009;65:1259–64.
Nelsen LM, Shields KE, Cunningham ML, Stoler JM,
Bamshad MJ, Eng PM, et al. Congenital malformations
among infants born to women receiving montelukast,
inhaled corticosteroids, and other asthma medications. J
Allergy Clin Immunol. 2012;129;251–4.
National Heart, Lung, and Blood Institute; National
Asthma Education and Prevention Program Asthma and
Pregnancy Working Group. NAEPP expert panel report.
Managing asthma during pregnancy: recommendations
for pharmacologic treatment-2004 update. J Allergy Clin
Immunol. 2005;115:36–46. Disponible en: www.nhlbi.
nih.gov/health/prof/lung/asthma/astpreg/astpreg_full.
pdf%5Cnhttp://scholar.google.com/scholar?hl=en&btnG
=Search&q=intitle:Working+group+report+on+managing
+asthma+during+pregnancy:+recommendations+for+phar
macologic+treatment#5.
Dombrowski MP, Schatz M, Wise R, Thom EA, Landon
M, Mabie W, et al.; National Institute of Child Health
and Human Development Maternal-Fetal Medicine Units
Network; National Heart, Lung, and Blood Institute.
Randomized trial of inhaled beclomethasone dipropionate
versus theophylline for moderate asthma during pregnancy.
Am J Obstet Gynecol. 2004;190:737–44.
Namazy JA, Murphy VE, Powell H, Gibson PG, Chambers
C, Schatz M. Effects of asthma severity, exacerbations and
oral corticosteroids on perinatal outcomes. Eur Respir J.
;41:1082–90.
Murphy KE, Hannah ME, Willan AR, Hewson SA,
Ohlsson A, Kelly EN, et al.; MACS Collaborative Group.
Multiple courses of antenatal corticosteroids for preterm
birth (MACS): a randomised controlled trial. Lancet.
;372:2143–51.
Schatz M, Dombrowski MP, Wise R, Momirova V, Landon
M, Mabie W, et al.; Maternal-Fetal Medicine Units
Network; The National Institute of Child Health and
Development; National Heart, Lung, and Blood Institute.
The relationship of asthma medication use to perinatal
outcomes. J Allergy Clin Immunol. 2004;113:1040–5.
Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME,
Beique L, Hunnisett L, et al. Birth defects after maternal
exposure to corticosteroids: prospective cohort study and
meta-analysis of epidemiological studies. Teratology.
;62:385–92.
Hviid A, Mølgaard-Nielsen D. Corticosteroid use during
pregnancy and risk of orofacial clefts. CMAJ. 2011;183:796–
Disponible en: http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=3080529&tool=pmcentrez&rende
rtype=abstract.
Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA,
Sørensen HT, Nørgaard M. Use of corticosteroids in early
pregnancy is not associated with risk of oral clefts and
other congenital malformations in offspring. Am J Ther.
;21:73–80.
Namazy J, Cabana MD, Scheuerle AE, Thorp JM
Jr, Chen H, Carrigan G, et al. The Xolair Pregnancy
Registry (EXPECT): the safety of omalizumab use during
pregnancy. J Allergy Clin Immunol. 2015;135:407–12.
Powell H, Murphy VE, Taylor DR, Hensley MJ,
McCaffery K, Giles W, et al. Management of asthma in
pregnancy guided by measurement of fraction of exhaled
nitric oxide: a double-blind, randomised controlled trial.
Lancet. 2011;378:983–90.
Martínez-Moragón E, Romero-Falcón A, García-Rivero
JL. Algorithm for the management of asthma in pregnant
women: a protocol to optimize processes in healthcare.
Expert Rev Respir Med. 2017;11:1003–12.
Gluck JC, Gluck PA. The effect of pregnancy on the course of
asthma. Immunol Allergy Clin North Am. 2006;26:63–80.
Schatz M, Dombrowski MP, Wise R, Thom EA, Landon
M, Mabie W, et al. Asthma morbidity during pregnancy
can be predicted by severity classification. J Allergy Clin
Immunol. 2003;112:283–8.
Enlaces refback
- No hay ningún enlace refback.